These results represent one of the most significant weight loss outcomes documented for any GLP-1 or dual-agonist therapy to date
[7] Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle
Contact your trial team or GP promptly if you experience: Persistent or severe nausea, vomiting, or diarrhoea that prevents adequate fluid or food intake Signs of dehydration, such as dizziness, dark urine, or reduced urination Severe or persistent abdominal pain, which may rarely indicate pancreatitis a known risk with GLP-1 receptor agonist therapies or gallbladder problems [18] [21] Rapid or irregular heartbeat (palpitations) Significant injection site reactions, including signs of infection (redness, warmth, swelling, or discharge) Symptoms of low blood sugar (hypoglycaemia) if you are also taking insulin or a sulfonylurea, such as shakiness, sweating, or confusion If you are unsure whether your symptoms require urgent attention, contact NHS 111 (by phone or online at 111.nhs.uk) for advice
Safety First: What to Avoid When choosing between skin treatments, avoid shortcuts that promise instant fairness
How Does Dr Shima Hadidchi Guide You Through the First Week of Semaglutide GLP-1
How Does Niacinamide Work
